Logo

NIH Awards SRI, UCSF $10M to Study PGx of Nicotine Addiction

Jan 25, 2006

NEW YORK, Jan. 25 (GenomeWeb News) - The National Institutes of Health has awarded a five-year, $10 million grant to the University of California, San Francisco and SRI International to study the pharmacogenetics of nicotine addiction and treatment, SRI announced today.

 

SRI also announced the formation of a new molecular genetics program to analyze genetic predispositions to addiction and susceptibility for certain cancers.  

 

The long-term research objectives of the program are to "better individualize treatment for tobacco dependence, facilitate the development of novel medications, and reduce the impact of smoking as a major health problem," the organization said in a statement.

 

Principal investigators for the program are Huijun Ring of SRI and Neil Benowitz of UCSF.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.